Abstract
No public abstract is available from the verified source records.
Xinwei Li, Heng Chen, Bifang He
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Therapeutic peptides: current applications and future directions
10.1038/s41392-022-00904-4 · 2022
Clinical trial cycle times continue to increase despite industry efforts
10.1038/nrd.2017.21 · 2017
Therapeutic peptides: recent advances in discovery, synthesis, and clinical translation
10.3390/ijms26115131 · 2025
Trends in peptide drug discovery
10.1038/s41573-020-00135-8 · 2021
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
10.1038/s41392-024-02107-5 · 2025
Peptide therapeutics: current status and future directions
10.1016/j.drudis.2014.10.003 · 2015
Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide
10.1021/acs.jmedchem.5b00726 · 2015
Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
10.1126/scitranslmed.aar7047 · 2018
Early engineering approaches to improve peptide developability and manufacturability
10.1208/s12248-014-9681-9 · 2015
Octreotide long-acting release (LAR): a review of its use in the management of acromegaly
10.2165/00003495-200363220-00014 · 2003
Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit
10.1016/j.ejphar.2010.09.019 · 2010
Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation
10.1124/jpet.112.199430 · 2013
DDAVP in the treatment of central diabetes insipidus
10.1056/nejm197603042941001 · 1976
An extracellular residue determines the agonist specificity of V2 vasopressin receptors
10.1016/0014-5793(95)00150-8 · 1995
Deep learning for advancing peptide drug development: tools and methods in structure prediction and design
10.1016/j.ejmech.2024.116262 · 2024
Machine intelligence in peptide therapeutics: a next-generation tool for rapid disease screening
10.1002/med.21658 · 2020
Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides
10.1093/bib/bbae275 · 2024
A comprehensive dataset of therapeutic peptides on multi-function property and structure information
10.1038/s41597-025-05528-1 · 2025
A review on antimicrobial peptides databases and the computational tools
2022
The FAIR Guiding Principles for scientific data management and stewardship
10.1038/sdata.2016.18 · 2016
Physicochemical and formulation developability assessment for therapeutic peptide delivery—a primer
10.1208/s12248-014-9688-2 · 2015
Principles of early drug discovery
10.1111/j.1476-5381.2010.01127.x · 2011
Deep learning in the discovery of antiviral peptides and peptidomimetics: databases and prediction tools
10.1007/s11030-025-11173-y · 2025
AI-driven discovery of antimicrobial peptides and derivatives: database and tools
10.37349/eds.2026.1008161 · 2026
Trends in GPCR drug discovery: new agents, targets and indications
10.1038/nrd.2017.178 · 2017
Machine-learning-guided peptide drug discovery: development of GLP-1 receptor agonists with improved drug properties
10.1021/acs.jmedchem.4c00417 · 2024
APD6: the antimicrobial peptide database is expanded to promote research and development by deploying an unprecedented information pipeline
10.1093/nar/gkaf860 · 2026
CAMPR4: a database of natural and synthetic antimicrobial peptides
10.1093/nar/gkac933 · 2023
DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics
10.1093/nar/gkaa991 · 2021
DRAMP 4.0: an open-access data repository dedicated to the clinical translation of antimicrobial peptides
10.1093/nar/gkae1046 · 2025
dbAMP 3.0: updated resource of antimicrobial activity and structural annotation of peptides in the post-pandemic era
10.1093/nar/gkae1019 · 2025
SATPdb: a database of structurally annotated therapeutic peptides
10.1093/nar/gkv1114 · 2016
10.1093/database/bay038
10.1093/database/bay038
PepTherDia: database and structural composition analysis of approved peptide therapeutics and diagnostics
10.1016/j.drudis.2021.02.019 · 2021
YADAMP: yet another database of antimicrobial peptides
10.1016/j.ijantimicag.2011.12.003 · 2012
Cppsite 2.0: an available database of experimentally validated cell-penetrating peptides predicting their secondary and tertiary structures
10.1016/j.jmb.2020.11.002 · 2021
10.1021/acs.chemrestox.5c00322
10.1021/acs.chemrestox.5c00322
CancerPPD2: an updated repository of anticancer peptides and proteins
2025
TumorHoPe2: an updated database for tumor homing peptides
2025
AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses
10.1093/nar/gkt1191 · 2014
Accurate structure prediction of cyclic peptides containing unnatural amino acids using HighFold3
10.1093/bib/bbaf488 · doi-reference
HLPpred-Fuse: improved and robust prediction of hemolytic peptide and its activity by fusing multiple feature representation
10.1093/bioinformatics/btaa160 · doi-reference
An end-user audit of reproducibility, data leakage, and overfitting of the top-ranked ADMET prediction models in TDC leaderboards
10.1021/acs.jcim.6c00819 · doi-reference
Revisiting ADMET prediction reliability under real-world challenges in the foundation model era
10.1186/s13321-026-01217-2 · doi-reference
Ziconotide: a clinical update and pharmacologic review
10.1517/14656566.2013.784269 · doi-reference
Scorpion peptides and ion channels: an insightful review of mechanisms and drug development
10.3390/toxins15040238 · doi-reference
Conotoxins targeting voltage-gated sodium ion channels
10.1124/pharmrev.123.000923 · doi-reference
Swiss-MODEL: homology modelling of protein structures and complexes
10.1093/nar/gky427 · doi-reference
The I-TASSER Suite: protein structure and function prediction
10.1038/nmeth.3213 · doi-reference
NCPepFold: accurate prediction of noncanonical cyclic peptide structures via cyclization optimization with multigranular representation
10.1021/acs.jctc.5c00139 · doi-reference
Cyclic peptide structure prediction and design using AlphaFold2
10.1038/s41467-025-59940-7 · doi-reference
PEPstrMOD: structure prediction of peptides containing natural, non-natural and modified residues
10.1186/s13062-015-0103-4 · doi-reference
AlgPred 2.0: an improved method for predicting allergenic proteins and mapping of IgE epitopes
10.1093/bib/bbaa294 · doi-reference
VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines
10.1186/1471-2105-8-4 · doi-reference
Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning
10.1126/sciadv.adj6367 · doi-reference
NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
10.1093/nar/gkaa379 · doi-reference
A large language model for predicting neurotoxic peptides and neurotoxins
10.1002/pro.70200 · doi-reference
An ensemble method for predicting and designing of druggable proteins
10.1002/prca.70046 · doi-reference
Prediction of cell-penetrating potential of modified peptides containing natural and chemically modified residues
10.3389/fmicb.2018.00725 · doi-reference
ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support
10.1093/nar/gkae236 · doi-reference
pepADMET: a novel computational platform for systematic ADMET evaluation of peptides
10.1021/acs.jcim.5c02518 · doi-reference
A PLM-based method for predicting protein ion channel modulators for drug discovery and safety evaluation
10.1002/pro.70689 · doi-reference
iCTX-Type: a sequence-based predictor for identifying the types of conotoxins in targeting ion channels
10.1155/2014/286419 · doi-reference
DeepB3P: a transformer-based model for identifying blood-brain barrier penetrating peptides with data augmentation using feedback GAN
10.1016/j.jare.2024.08.002 · doi-reference
Prediction of blood-brain barrier penetrating peptides based on data augmentation with Augur
10.1186/s12915-024-01883-4 · doi-reference
B3Pred: a random-forest-based method for predicting and designing blood-brain barrier penetrating peptides
10.3390/pharmaceutics13081237 · doi-reference
StackDPPIV: a novel computational approach for accurate prediction of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides
10.1016/j.ymeth.2021.12.001 · doi-reference
MLCPP 2.0: an updated cell-penetrating peptides and their uptake efficiency predictor
10.1016/j.jmb.2022.167604 · doi-reference
Machine-learning-based prediction of cell-penetrating peptides and their uptake efficiency with improved accuracy
10.1021/acs.jproteome.8b00148 · doi-reference
AIPpred: sequence-based prediction of anti-inflammatory peptides using random forest
10.3389/fphar.2018.00276 · doi-reference
mACPpred 2.0: stacked deep learning for anticancer peptide prediction with integrated spatial and probabilistic feature representations
10.1016/j.jmb.2024.168687 · doi-reference
mACPpred: a support vector machine-based meta-predictor for identification of anticancer peptides
10.3390/ijms20081964 · doi-reference
MLACP: machine-learning-based prediction of anticancer peptides
10.18632/oncotarget.20365 · doi-reference
ACPred-FL: a sequence-based predictor using effective feature representation to improve the prediction of anti-cancer peptides
10.1093/bioinformatics/bty451 · doi-reference
CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site
10.1093/nar/gkv456 · doi-reference
HPEPDOCK: a web server for blind peptide-protein docking based on a hierarchical algorithm
10.1093/nar/gky357 · doi-reference
The HADDOCK2.4 web server for integrative modeling of biomolecular complexes
10.1038/s41596-024-01011-0 · doi-reference
Generative latent diffusion language modeling yields anti-infective synthetic peptides
10.1016/j.celbio.2025.100183 · doi-reference
Target sequence-conditioned design of peptide binders using masked language modeling
10.1038/s41587-025-02761-2 · doi-reference
De novo design of protein structure and function with RFdiffusion
10.1038/s41586-023-06415-8 · doi-reference